Dual-Prep registry: atherectomy Devices and intravascUlAr Lithotripsy for the PREParation of heavily calcified coronary lesions registry, 1-year Results
Nakamura, M.; Kiriyama, N.; Tanaka, Y.; Yamazaki, S.; Kawasaki, T.; Muramatsu,, T.; Kadota, K.; Ashikaga, T.; Takahashi, A.; Otsuji, S.; Ando, K.; Ishida, M.; Nakamura, S.; Ito, Y.; Iijima, R.; Nakazawa, G.; Shite, J.; Honye, J.; Ako, J.; Yokoi, H.; Kozuma, K.; Otake, H.; Kochi, K.; Yamada, T.; Sotomi, Y.
Show abstract
BackgroundCombination therapy with atherectomy and intravascular lithotripsy (IVL) has emerged as a promising strategy for the treatment of severely calcified occlusive coronary lesions, which potentially enhances procedural efficacy without increasing complication risk. MethodsThe Dual-Prep Registry is a multicenter, prospective registry designed to evaluate the safety and efficacy of IVL after atherectomy in severely calcified lesions. Combined use was selectively applied when the risk of complications was anticipated to be high with a larger atherectomy burr size, or when it was deemed non-beneficial due to unfavorable guidewire bias. All adverse events were adjudicated by a clinical events committee. Kaplan-Meier analysis was performed to evaluate the primary endpoint of major adverse cardiovascular events (MACE; composite endpoint of cardiac death, myocardial infarction, and target vessel revascularization [TVR]) at 1 year. ResultsA total of 118 cases (120 lesions) were enrolled across 20 facilities. Significant comorbidities included diabetes in 56.8% of patients and hemodialysis-dependence in 25.4%. Calcification score after atherectomy was 4.0 in all cases, and calcified nodules were present in 56.4% (core-lab analysis) of cases. One-year follow-up was complete in 99.2% patients. MACE occurred in 7.6% patients at one year (cardiac death 2.5%, myocardial infarction 5.1%, TVR 5.1%) and stent thrombosis was observed in 1 case. ConclusionsAtherectomy followed by IVL resulted in low 1-year rates of MACE, TVR, and stent thrombosis in patients with severely calcified coronary lesions. This approach may be considered for lesions where an "IVL-first" strategy is difficult to apply. Japan Registry of Clinical Trials: jRCT1032230384. URL: https://jrct.mhlw.go.jp A Clinical Perspective1) What Is New? O_LIElective combined use of IVL and atherectomy resulted in low 1 year MACE and TLR. C_LIO_LIThe incidence of MACE was higher in cases with greater residual stenosis after the procedure and a larger baseline reference vessel diameter. C_LI 2) What Are the Clinical Implications? O_LICombining IVL with atherectomy may serve as an effective treatment strategy in cases where IVL-first approaches are difficult to apply. C_LIO_LISevere calcified lesions that are presumed to be unresponsive to RA/OA treatment or carry a high risk of RA/OA complications may be good candidates for this strategy. C_LI
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Ticagrelor vs Clopidogrel: the Impact of Platelet Inhibition on Cerebrovascular Microembolic Events during TAVR 96%
- Direct Oral Anticoagulants Affect Activated Clotting Time During and Bleeding Events After Percutaneous Coronary Intervention 96%
- Sodium-glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome with Diabetes Mellitus 96%
Similar papers in this journal
- Two-Year Real World Clinical Outcomes after Intravascular Imaging Device Guided Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable-Polymer Sirolimus-Eluting Stent 98%
- Utility of the CHADS-P 2 A 2 RC score for estimating net adverse clinical events in chronic coronary syndrome patients without atrial fibrillation: insights from the CLIDAS-PCI 96%
- Temporal Variations in Ischemic and Bleeding Event Risks after Acute Coronary Syndrome during Dual Antiplatelet Therapy 95%
Similar papers in this journal
- Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia. The Randomized RAIN-FLOW Study 96%
- Prognostic Value of Patient-Reported Outcomes in Predicting Long-term Mortality after Transcatheter Aortic Valve Replacement (TAVR) 94%
- Age-stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan 94%
Similar papers in this journal
- Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial 94%
- Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial 92%
- Comparison of Long-term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis 92%
Similar papers in this journal
- Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services 95%
- Improved Hemodynamic Performance and Reduced Paravalvular Regurgitation with the SAPIEN 3 Ultra RESILIA Valve: A Propensity-Matched Single-Center TAVR Study 94%
- Autologous cardiac micrografts as support therapy to coronary artery bypass surgery 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.